Home/Filings/4/0000950170-25-008393
4//SEC Filing

TAYMANS JILL M 4

Accession 0000950170-25-008393

CIK 0000862692other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 5:00 PM ET

Size

10.8 KB

Accession

0000950170-25-008393

Insider Transaction Report

Form 4
Period: 2025-01-21
TAYMANS JILL M
VP Finance, CFO
Transactions
  • Award

    Stock Option

    2025-01-21$7.35/sh+10,000$73,50010,000 total
    Exercise: $7.35From: 2025-01-21Exp: 2030-01-21Common Stock (10,000 underlying)
Holdings
  • Stock Option

    Exercise: $4.62From: 2023-01-13Exp: 2028-01-13Common Stock (20,000 underlying)
    20,000
  • Stock Option

    Exercise: $5.88From: 2023-12-22Exp: 2028-12-22Common Stock (10,000 underlying)
    10,000
  • Stock Option

    Exercise: $8.00From: 2020-09-23Exp: 2027-09-23Common Stock (7,000 underlying)
    7,000
  • Common Stock

    45,396
  • Stock Option

    Exercise: $3.10From: 2019-06-02Exp: 2026-06-02Common Stock (7,500 underlying)
    7,500
Footnotes (3)
  • [F1]Stock options vest 1/5 per year commencing on September 23, 2020.
  • [F2]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
  • [F3]Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.

Documents

1 file

Issuer

CRYO CELL INTERNATIONAL INC

CIK 0000862692

Entity typeother

Related Parties

1
  • filerCIK 0001261283

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:00 PM ET
Size
10.8 KB